Open Access

Table 3

Health claims [Article 14(1)(b)] refused concerning marine lipids.

Refused
Nutrient, substance,
food or food category
Claim Reasons for rejection EFSA opinion reference Commission Regulation
Docosahexaenoic Acid (DHA)
and eicosapentaenoic acid (EPA)
contained in I omega
kids®/Pufan 3 kids®
Calming Non-compliance with the Regulation as,
on the basis of the evidence presented
in the dossier – a cause and effect
relationship between the consumption
of the food for which the claim is made
and the claimed effect has not been
established.
Q-2008-091 & Q-2008-096 Commission Regulation (EC) No 983/2009 of 21/10/2009
Provide serenity and room for
a beneficial development of the child
Q-2008-092 & Q-2008-097
Help to promote the thinking capacity Q-2008-093 & Q-2008-101
Help to promote concentration Q-2008-094 & Q-2008-099
Help to support vision Q-2008-095 & Q-2008-100
Help to support mental development Q-2008-098 & Q-2008-104
Help to support the learning ability Q-2008-102 & EFSA-Q-2008-103

Eye q baby®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Eye q baby® provides the nourishments that support healthy central nervous system development Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-119 Commission Regulation (EC) No 1024/2009 of 29/10/2009
Eye q® provides the nourishments that help to maintain healthy brain functions Q-2008-329
Eye q® provides the nourishment that help children to maintain concentration levels Q-2008-330

Mumomega®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Mumomega® provides the nourishments that support healthy central nervous system development Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-328 Commission Regulation (EC) No 1024/2009 of 29/10/2009

Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) DHA and ARA support neural development of the brain and eyes Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-120 Commission Regulation (EC) No 983/2009 of 21/10/2009

Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain coordination Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-121 Commission Regulation (EC) No 1024/2009 of 29/10/2009
Efalex® may help maintain concentration Q-2008-317
Efalex® may help maintain and support brain development and function Q-2008-318
Efalex® may help maintain learning ability Q-2008-319
Efalex® may help maintain and support eye development and function Q-2008-320

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.